23andMe Ancestry Service - DNA Test Kit, Personalized Genetic Legacy, 4,500+ Geographic Regions, Ancestry Test, Family Tree, DNA Relative Finder, Origins, Ethnicities, Traits, Ancestry Reports

WHAT YOU GET: At-home DNA test kit with access to the most detailed geographic breakdown, sometimes to the specific valley—or even village—your ancestors hail from. Our innovative ancestry composition estimates your ancestry across 4,500+ geographic regions. Discover if you’re connected to historical groups including members of ancestral migrations like the Mayflower Descendants, the Pennsylvania Dutch, and Mississippi Delta Creoles. Listed in TIME’s Best Inventions Hall of Fame 2025. ANCESTRY FEATURES: Dig deeper into your ancestry with even more enhanced accuracy and the most comprehensive DNA ancestry test. Go back in time with Ancestry Timeline to gain a clearer picture of when your most recent ancestors from each population lived. Discover your Neanderthal ancestry and family origins, including maternal and paternal lines. Opt-in to DNA Relative Finder to find and connect with people who share your DNA. Automatic Family Tree makes it easy to see your DNA relationships. TRAIT REPORTS: Find out what makes you, you with personalized trait reports. Uncover the science behind your unique characteristics. Explore over 30 personal trait reports, including on hair color, taste preferences (like aversion to cilantro), perfect pitch, sleep habits, risk of mosquito bites, and more. Learn what your DNA has to say about what makes you unique with fun, personalized genetic reports. EASY, AT-HOME DNA TEST: Simple saliva collection kit – no blood, no needles. Register your ancestry test kit online using the barcode, spit in the tube, and mail your DNA sample back in the prepaid box. Get your personalized genetic reports in just 4–5 weeks. Start exploring your ancestry and traits from home. Upgrade to advanced ancestry with 23andMe+ Premium at anytime from your account. PRIVATE & SECURE: Your DNA data is encrypted, protected, and always under your control. We implement enhanced security measures to keep your information safe. You choose what to learn and what to share. Privacy by design ensures your personal information is kept confidential. Subject to 23andMe’s Terms of Service at 23andme. com/tos and Privacy Statement at 23andme. com/about/privacy. * The 23andMe PGS test includes health predisposition and carrier status reports. Health predisposition reports include both reports that meet FDA requirements for genetic health risks and reports which are based on 23andMe research and have not been reviewed by the FDA. The test uses qualitative genotyping to detect select clinically relevant variants in the genomic DNA of adults from saliva for the purpose of reporting and interpreting genetic health risks and reporting carrier status. It is not intended to diagnose any disease. Your ethnicity may affect the relevance of each report and how your genetic health risk results are interpreted. Each genetic health risk report describes if a person has variants associated with a higher risk of developing a disease, but does not describe a person?s overall risk of developing the disease. The test is not intended to tell you anything about your current state of health, or to be used to make medical decisions, including whether or not you should take a medication, how much of a medication you should take, or determine any treatment. Our carrier status reports can be used to determine carrier status, but cannot determine if you have two copies of any genetic variant. These carrier reports are not intended to tell you anything about your risk for developing a disease in the future, the health of your fetus, or your newborn child's risk of developing a particular disease later in life. For certain conditions, we provide a single report that includes information on both carrier status and genetic health risk. **23andMe PGS Pharmacogenetics reports: The 23andMe test uses qualitative genotyping to detect 3 variants in the CYP2C19 gene, 2 variants in the DPYD gene and 1 variant in the SLCO1B1 gene in the genomic DNA of adults from saliva for the purpose of reporting and interpreting information about the processing of certain therapeutics to inform discussions with a healthcare professional. It does not describe if a person will or will not respond to a particular therapeutic and does not describe the association between detected variants and any specific therapeutic. Our CYP2C19 Pharmacogenetics report provides certain information about variants associated with metabolism of some therapeutics and provides interpretive drug information regarding the potential effect of citalopram and clopidogrel therapy. Results for SLCO1B1 and DPYD and certain CYP2C19 results should be confirmed by an independent genetic test prescribed by your own healthcare provider before taking any medical action. Warning: Test information should not be used to start, stop, or change any course of treatment and does not test for all possible variants that may affect metabolism or protein function. The PGS test is not a substitute for visits to a healthcare professional. Making changes to your current regimen can lead to harmful side effects or reduced intended benefits of your medication, therefore consult with your healthcare professional before taking any medical action. For important information and limitations regarding Pharmacogenetics reports, visit 23andme. com/test-info/pharmacogenetics/ Membership auto-renews at then-current rate, unless canceled in advance. Once a 23andMe+ membership has ended, customer will lose access to 23andMe+ reports and features; customer will retain access to Health+Ancestry Service reports and features. Terms apply. Before you can use 23andMe and see your reports, you must agree to 23andMe's Terms of Service and Membership Terms at the time of registration of your 23andMe kit. Your use of 23andMe is further subject to 23andMe's Privacy Statement. For use in the USA only - kits shipped or used outside the US will be invalidated and no refund will be provided. Kits may not be redistributed or resold. 23andMe Claim Substantiation for "80% get genetically meaningful health info." Date range: August 2020 - August 2021. Source: 23andMe internal data.